Cataract and genetic diseases
DOI:
https://doi.org/10.12775/QS.2024.24.54884Keywords
cataract, risk factors, genetic diseasesAbstract
Despite the decreasing number of cases, cataract is still the leading cause of visual impairment and blindness worldwide. The search for the causes of this disease, its risk factors and the relationship with systemic diseases is the subject of many studies and attracts the attention of scientists around the world.One of the most common cause of cataract and probably the most frequently reported in the literature, is aging. Other commonly described causes of cataracts are external factors and acquired diseases. Although genetic diseases are not the most common disorders associated with the occurrence and development of cataract, this review takes a broader look at this particular aspect, describing the relationship between cataracts and a group of genetic diseases. The links between cataracts and genetic diseases have been investigated. This review focuses on the diseases most frequently reported in the literature to be associated with cataracts, such as Down syndrome, myotonic dystrophy, neurofibromatosis type 2, Marfan syndrome, Wilson disease and Alport syndrome. The associations of cataracts with various genetic diseases, confirmed in previously published studies, were described. Despite the fact that it is difficult to distinguish individual factors influencing the development of cataract, the analyzed literature examples allowed to demonstrate that cataract in the course of the genetic disorders discussed in this review is not accidental.
References
Lee C M, Afshari N A, The global state of cataract blindness. Curr. Opin. Ophthalmol. 2017; 28(1): 98–103. https://doi.org/10.1097/ICU.0000000000000340.
World Health Organisation, Blindness and vision impairment, WHO website https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment (access: 15.03.2024)
Robman L, Taylor H, External factors in the development of cataract. Eye 2005; 19(10): 1074–1082. https://doi.org/10.1038/sj.eye.6701964.
Ang M J, Afshari N A, Cataract and systemic disease: A review. Clin. Exp. Ophthalmol. 2021; 49(2): 118–127. https://doi.org/10.1111/ceo.13892.
Liu Y C, Wilkins M, Kim T, et al. Cataracts. The Lancet 2017; 390(10094): 600-612. https://doi.org/10.1016/S0140-6736(17)30544-5.
Chua J, Koh J, Tan A, et al. Ancestry, Socioeconomic Status, and Age-Related Cataract in Asians. Ophthalmology 2015; 122(11): 2169–2178. https://doi.org/10.1016/j.ophtha.2015.06.052.
Haseeb A, Huynh E, ElSheikh R, et al. Down syndrome: a review of ocular manifestations. Ther. Adv. Ophthalmol. 2022; 14: 25158414221101718. https://doi.org/10.1177/25158414221101718.
Sun E, Kraus C L, The Ophthalmic Manifestations of Down Syndrome. Children 2023; 10(2): 341. https://doi.org/10.3390/children10020341.
Jain A, Boyd N K, Paulsen K C, et al. Ophthalmologic and neuro-ophthalmologic findings in children with Down syndrome. Am. J. Med. Genet. C. Semin. Med. 2023; 193(4): e32068. https://doi.org/10.1002/ajmg.c.32068.
Haargaard B, Down’s syndrome and early cataract. Br. J. Ophthalmol. 2006; 90(8): 1024–1027. https://doi.org/10.1136/bjo.2006.090639.
Ozimski L L, Sabater-Arcis M, Bargiela A, et al. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol. Rev. 2020; 96(2): 716-730. https://doi.org/10.1111/brv.12674.
Kang M, Yim H, Hwang H, Two cases of myotonic dystrophy manifesting various ophthalmic findings with genetic evaluation. Indian J. Ophthalmol. 2016; 64(7): 535. https://doi.org/10.4103/0301-4738.190157.
Hasuike Y, Mochizuki H, Nakamori M, Cellular Senescence and Aging in Myotonic Dystrophy. Int. J. Mol. Sci. 2022; 23(4):2339. https://doi.org/10.3390/ijms23042339.
Thornton C A, Myotonic Dystrophy. Neurol. Clin. 2014; 32(3): 705–719. https://doi.org/10.1016/j.ncl.2014.04.011.
Evans D, Neurofibromatosis type 2 (NF2): A clinical and molecular review. Orphanet. J. Rare Dis. 2009; 4(1): 16. https://doi.org/10.1186/1750-1172-4-16.
Asthagiri A R, Parry D, Butman J, et al. Neurofibromatosis type 2. The Lancet 2009; 373(9679): 1974–1986. https://doi.org/10.1016/S0140-6736(09)60259-2.
McLaughlin M E, Ocular Pathologic Findings of Neurofibromatosis Type 2. Arch. Ophthalmol. 2007; 125(3): 389. https://doi.org/10.1001/archopht.125.3.389.
Coelho S G, Almeida A G, Síndrome de Marfan revisitada – da genética à clínica. Rev. Port. Cardiol. 2020; 39(4): 215–226. https://doi.org/10.1016/j.repc.2019.09.008.
Esfandiari H, Ansari S, Mohammad-Rabei H, et al. Management strategies of ocular abnormalities in patients with marfan syndrome: Current perspective. J. Ophthalmic. Vis. Res. 2019; 14(1): 71. https://doi.org/10.4103/jovr.jovr_29_18.
Sandvik G F, Vanem T T, Rand‐Hendriksen S, et al. Ten‐year reinvestigation of ocular manifestations in Marfan syndrome. Clin. Exp. Ophthalmol. 2019; 47(2): 212–218. https://doi.org/10.1111/ceo.13408.
Chevalier K, Mauget-Faÿsse M, Vasseur V, et al. Eye Involvement in Wilson’s Disease: A Review of the Literature. J. Clin. Med. 2022; 11(9): 2528. https://doi.org/10.3390/jcm11092528.
Prasad D, Bhriguvanshi A, Ocular manifestations of liver disease in children: Clinical aspects and implications. Ann. Hepatol. 2020; 19(6): 608–613. https://doi.org/10.1016/j.aohep.2019.11.009.
Langwińska-Wośko E, Litwin T, Dzieżyc K, et al. The sunflower cataract in Wilson’s disease: pathognomonic sign or rare finding? Acta Neurol. Belg. 2016; 116(3): 325–328. https://doi.org/10.1007/s13760-015-0566-1.
Adone A, Anjankar A, Alport Syndrome: A Comprehensive Review. Cureus 2023; 15(10): e47129. https://doi.org/10.7759/cureus.47129.
Ang M J, Afshari N A, Cataract and systemic disease: A review. Clin. Exp. Ophthalmol. 2021; 49(2): 118–127. https://doi.org/10.1111/ceo.13892.
Savige J, Sheth S, Leys A, et al. Ocular Features in Alport Syndrome. Clin. J. Am. Soc. Nephrol. 2015; 10(4): 703–709. https://doi.org/10.2215/CJN.10581014.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mateusz Kozik, Nina Skalska-Dziobek, Weronika Małagocka, Maria Rozpłoch-Sapa, Karolina Chybowska, Mateusz Orłowski, Maria Naruszewicz, Przemysław Cetnarowski, Aleksandra Midro, Karol Zagórski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 33
Number of citations: 0